State Street Corp Grifols Sa Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Grifols Sa stock. As of the latest transaction made, State Street Corp holds 455,725 shares of GRFS stock, worth $3.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

455,725

Previous 700,791 34.97%

Holding current value

$3.4 Million

Previous $6.22 Million 45.52%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.99 - $9.55 $1.71 Million - $2.34 Million	-245,066 Reduced 34.97%	455,725 $3.39 Million
Q3 2024 Nov 14, 2024	SELL	$6.28 - $9.38 $608,990 - $909,606	-96,973 Reduced 12.16%	700,791 $6.22 Million
Q2 2024 Aug 14, 2024	BUY	$6.27 - $7.7 $2.3 Million - $2.82 Million	366,347 Added 84.92%	797,764 $5.03 Million
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $81,743 - $170,062	14,944 Added 3.59%	431,417 $2.88 Million
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $228,038 - $341,910	-29,577 Reduced 6.63%	416,473 $4.81 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $104,478 - $127,930	11,726 Added 2.7%	446,050 $4.08 Million
Q2 2023 Aug 14, 2023	SELL	$7.14 - $9.29 $21.5 Million - $28 Million	-3,015,076 Reduced 87.41%	434,324 $3.98 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $167,220 - $268,810	25,146 Added 0.73%	3,449,400 $25.4 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $1.62 Million - $2.32 Million	272,103 Added 8.63%	3,424,254 $29.1 Million
Q3 2022 Nov 15, 2022	BUY	$5.95 - $14.3 $38,222 - $91,863	6,424 Added 0.2%	3,152,151 $18.8 Million
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $1.36 Million - $1.7 Million	-127,959 Reduced 3.91%	3,145,727 $37.3 Million
Q1 2022 May 16, 2022	BUY	$10.37 - $12.73 $341,753 - $419,529	32,956 Added 1.02%	3,273,686 $38.2 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $650,877 - $973,447	63,749 Added 2.01%	3,240,730 $36.8 Million
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $39 Million - $47.9 Million	2,770,629 Added 681.83%	3,176,981 $46.4 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $1.34 Million - $1.52 Million	80,506 Added 24.71%	406,352 $7.05 Million
Q1 2021 May 17, 2021	SELL	$15.15 - $19.78 $1.2 Million - $1.56 Million	-78,964 Reduced 19.51%	325,846 $5.63 Million
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $926,288 - $1.08 Million	54,940 Added 15.7%	404,810 $7.47 Million
Q3 2020 Nov 10, 2020	BUY	$15.4 - $20.16 $1.06 Million - $1.39 Million	69,000 Added 24.57%	349,870 $6.07 Million
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $526,278 - $618,896	-28,853 Reduced 9.32%	280,870 $5.12 Million
Q1 2020 May 11, 2020	BUY	$16.28 - $25.63 $5.04 Million - $7.94 Million	309,723 New	309,723 $6.24 Million

Others Institutions Holding GRFS

# of Institutions

169

Shares Held

145M

Call Options Held

166K

Put Options Held

103K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.06B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Grifols Sa Transaction History